Susan Hasty, Publisher
Table of Contents . . . July 22nd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
End-Stage Liver Disease - Advances no longer preclude transplantations for hepatitis B virus
Ultrasound - Doppler images distinguish acute alcoholic hepatitis from cirrhosis
Chemotherapy - Cancer agent Doxil improves outcomes after ablation of liver tumors
Poisoning - Livers from those with methanol intoxication acceptable for organ recipients
Tumor Markers - Protein offers new way to detect liver cancer in people with cirrhosis
Bioengineering - Coating polymers with growth factor improves liver cell transplantation
Bone Marrow Transplantation - Color ultrasound-guided biopsy useful for diagnosing post-transplant liver damage
Chronic Liver Diseases - Codevelopment and license agreement for signed for NCX 1000
Hepatitis C - Pegasys marketing authorization granted by European Commission
Hepatocellular Carcinoma - Vaccine incorporating encapsulated cytokines protects against liver cancer recurrence
Liver Cancer - Chemoembolization offers survival benefit
Market Trends - Worldwide hepatitis C market expected to reach $3.97 billion by 2007
Vaccine Development - Plexus acquires exclusive position for demographically targeted T-cell vaccine discovery
Vaccine Research - Vaccine experts report progress in vaccine development
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.